Rheumatoid factors, anti-filaggrin antibodies, and low in vitro interleukin 2 and interferonγ production are useful immunological markers for early diagnosis of community cases of rheumatoid arthritis. Preliminary study

Revue du Rhumatisme (Edition Francaise)

Volumn 68, Issue 3, 2001, Pages 239-249

  Vittecoq, Olivier ^a   Jouen Beades, Fabienne ^a   Krzanowska, Kataryna ^a   Bichon Tauvel, Isabelle ^a   Ménard, Jean François ^a   Daragon, Alain ^a   Tron, François ^a   Le Loët, Xavier ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Anti Sa antibodies; Antifillagrine antibodies; Cytokines; Rheumatoid factor isotypes; Very early rheumatoid arthritis

Indexed keywords

ANTINUCLEAR ANTIBODY; ANTIPERINUCLEAR FACTOR; AUTOANTIBODY; BIOLOGICAL MARKER; FILAGGRIN ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; KERATIN ANTIBODY; PROTEIN ANTIBODY; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGGLUTINATION TEST; ANTIBODY DETECTION; ARTICLE; BLOOD; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE DURATION; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; IMMUNOASSAY; IMMUNOPATHOLOGY; PATIENT CODING; POLYARTHRITIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

EID: 0035725001     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1169-8330(01)00002-3     Document Type: Article

References (43)

1. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
2. Quantitative detection of class-specific rheumatoid factors using mouse monoclonal antibodies and the biotin/streptavidin enhancement system
3. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies
4. The antiperinuclear factor (APF) and antikeratin antibodies (AKA) in rheumatoid arthritis
5. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process
6. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: Comparison with rheumatoid factor
7. The Sa system: A novel antigen-antibody system specific for rheumatoid arthritis
8. TNF-α. A pivotal role in rheumatoid arthritis
9. Th1/Th2 cytokine balance in arthritis
10. Direct stimulation of cytokines (IL1-β, TNF-α, IL6, IL2, IFN-γ and GM-CSF) in whole blood. II. Application to rheumatoid arthritis and osteoarthritis
11. Cytokine production in whole blood cell cultures of patients with rheumatoid arthritis and collagenosis
12. Circulating concentration and production of cytokines and soluble receptors in rheumatoid arthritis patients: Effect of a single dose methotrexate
13. An open study of pentoxifylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis
14. Cytokine production in whole blood cell cultures of patients with rheumatoid arthritis
15. Direct stimulation of cytokines (IL1-β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation
16. How many joints in the hands and the wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?
17. Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factor assays in rheumatoid arthritis
18. The antiperinuclear factor. 1. Clinical and serological associations
19. High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called « antikeratin antibodies »
20. Anti-RA33 antinuclear autoantibody in rheumatoid arthritis and mixed connective tissue disease: Comparison with antikeratin and antiperinuclear antibodies
21. Natural IgG to epidermal cytokeratin vs IgG to the stratum corneum of the rat oesophagus epithelium, so-called « antikeratin antibodies », in rheumatoid arthritis and other rheumatic diseases
22. Anticorps antipérinucléaires et antigènes correspondants
23. Clinical heterogeneity of rheumatoid arthritis and the antiperinuclear factor
24. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis
25. Anticorps antistratum corneum d'œsophage de rat, auto-anticorps antikératine épidermique et anti-épiderme dans la polyarthrite rhumatoïde et différentes affections rhumatologiques
26. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis
27. Antiperinuclear factor and antikeratin antibodies in rheumatoid arthritis
28. Normal human epidermal keratinocytes express in vitro specific molecular forms of (pro)filaggrin recognized by rheumatoid arthritis-associated antifilaggrin autoantibodies
29. The value of the ACR-criteria in very early rheumatoid arthritis
30. Lack of concordance between criteria based diagnoses and clinical diagnoses in a cohort of patients with early synovitis
31. He diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide
32. Purification of filaggrin from human epidermis and measurement of anti-filaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay
33. Diagnostic value of antikeratin antibodies in rheumatoid arthritis
34. Significance of antikeratin antibodies in rheumatoid arthritis
35. Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases
36. Antibodies anti-keratin: Diagnostic and prognostic markers for early rheumatoid arthritis
37. Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleo-protein complex
38. Antibodies from patients with rheumatoid arthritis and systemic lupus erythematosus recognize different epitopes of a single heterogeneous nuclear RNP core protein. Possible role of cross-reacting antikeratin antibodies
39. Autoantibodies in rheumatoid arthritis
40. Stimulation of whole blood cultures in patients with ankylosing spondylitis by a mitogen derived from mycoplasma arthritis (MAS) and other mitogens
41. Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins
42. Interleukin-10 in rheumatoid arthritis
43. Elevated interleukin-10 levels in patients with rheumatoid arthritis